Epigral1105.30
+3.90 (+0.35%)

Epigral Share Price

1105.30+3.90 (+0.35%)
-37.31% past 1 Year

Corporate filings & documents

Announcements

Epigral Limited (the Company) hereby informs that the officials of the Company are participating in Anand Rathi Annual Flagship Conference: G-200 Summit 2026 scheduled on 21.09.2026.
4 days ago
Epigral Limited (the Company) hereby informs that the officials of the Company are participating in Anand Rathi Annual Flagship Conference: G-200 Summit 2026 scheduled on 21.09.2026.
4 days ago
Epigral Limited has informed the Exchange about Investor / Analyst Plant Visit on Thursday 03.09.2026
2 weeks ago
Epigral Limited has informed the Exchange about Investor / Analyst Plant Visit on Thursday 03.09.2026
2 weeks ago
Epigral Limited has informed the Exchange about One-on-One Meeting with Investor / Analyst on thursday 20.08.2026
1 month ago
Epigral Limited has informed the Exchange about One-on-One Meeting with Investor / Analyst on thursday 20.08.2026
1 month ago
Epigral Limited hereby informs that the officials of the Company are participating in EMKAY Confluence 2026 on 12th August 2026
1 month ago
Epigral Limited hereby informs that the officials of the Company are participating in EMKAY Confluence 2026 on 12th August 2026
1 month ago
Epigral Limited informs that the Company is having One-on-One Meeting with Investor / Analyst on Monday 3rd august 2026.
1 month ago
Epigral Limited informs that the Company is having One-on-One Meeting with Investor / Analyst on Monday 3rd august 2026.
1 month ago
Epigral Limited submits Transcript of Conference Call discussing Q1 FY27 Results.
1 month ago
Epigral Limited submits Transcript of Conference Call discussing Q1 FY27 Results.
1 month ago
Newpaper Publication - Un-Audited Financial Results for the First Quarter ended 30.06.2026
1 month ago
Newpaper Publication - Un-Audited Financial Results for the First Quarter ended 30.06.2026
1 month ago
Newspaper Publication - Un-Audited Financial Results for the First Quarter ended 30.06.2026
1 month ago
Audio Recording of Conference Call discussing Q1 FY27 Results held on Monday 27th July 2026 at 5.00 p.m.
1 month ago
Audio Recording of Conference Call discussing Q1 FY27 Results held on Monday 27th July 2026 at 5.00 p.m.
1 month ago
Investor Presentation Q1 FY 27.
1 month ago
Investor Presentation Q1 FY 27.
1 month ago
Press Release of Un-Audited Financual results - Q1FY27.
1 month ago
Press Release of Un-Audited Financual results - Q1FY27.
1 month ago
As part of the Companys strategic growth and expansion initiatives it proposes to establish a new manufacturing facility for Epoxy Resin and formulations and Multi Purpose Plant at its existing facility at Dahej Gujarat.
1 month ago
As part of the Companys strategic growth and expansion initiatives it proposes to establish a new manufacturing facility for Epoxy Resin and formulations and Multi Purpose Plant at its existing facility at Dahej Gujarat.
1 month ago
Outcome of Board Meeting held on Monday 27th July 2026 and submission of Un-Audited Financial Results (Standalone & Consolidated) for the First Quarter ended 30th June 2026.
1 month ago
Outcome of Board Meeting held on Monday 27th July 2026 and submission of Un-Audited Financial Results (Standalone & Consolidated) for the First Quarter ended 30th June 2026.
1 month ago
UNAUDITED FINANCIAL RESULTS - 30.06.2026.
1 month ago
UNAUDITED FINANCIAL RESULTS - 30.06.2026.
1 month ago
Epigral Limiteds reply to clarification sought by the Stock Exchange with reference to Movement in Volume.
2 months ago
Epigral Limiteds reply to clarification sought by the Stock Exchange with reference to Movement in Volume.
2 months ago
Epigral Limited has informed the Exchange about Conference Call on Monday 27th July 2026 to discuss Q1 FY27 Results
2 months ago
Epigral Limited has informed the Exchange about Conference Call on Monday 27th July 2026 to discuss Q1 FY27 Results
2 months ago
The Exchange has sought clarification from Epigral Ltd on July 22 2026 with reference to Movement in Volume. <BR><BR>The reply is awaited.
2 months ago
The Exchange has sought clarification from Epigral Ltd on July 22 2026 with reference to Movement in Volume. <BR><BR>The reply is awaited.
2 months ago
Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2026 inter alia to consider and approve Un-audited Financial Results (Standalone & Consolidated) of the Company for the First Quarter ended on 30th June 2026.
2 months ago
Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2026 inter alia to consider and approve Un-audited Financial Results (Standalone & Consolidated) of the Company for the First Quarter ended on 30th June 2026.
2 months ago
Revised Credit Rating.
2 months ago
Revised Credit Rating.
2 months ago
Epigral Limited submits certificate under Reg. 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 30.06.2026
2 months ago
Epigral Limited submits certificate under Reg. 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 30.06.2026
2 months ago
Epigral Limited has informed the Exchange about Incorporation of a Wholly owned Subsidiary namrly "Epigral Advanced Materials Limited".
2 months ago
Epigral Limited has informed the Exchange about Incorporation of a Wholly owned Subsidiary namrly "Epigral Advanced Materials Limited".
2 months ago
Epigral Limited submits Notice of Closure of Trading Window
2 months ago
Epigral Limited submits Notice of Closure of Trading Window
2 months ago
Epigral Limited has informed the Exchange about One-on-One Meeting through V.C. with Investor / Analyst on June 16 2026.
3 months ago
Submission of Scrutinizers Report of 19th AGM held on 08.06.2026.
3 months ago
Submission of Scrutinizers Report of 19th AGM held on 08.06.2026.
3 months ago
Proceedings of 19th AGM held on 08.06.2026.
3 months ago
Epigral Limited submit Review of CRISIL Ratings on the Bank Facilities of Epigral Limited.
3 months ago
Annual Secretarial Compliance Report - 31.03.2026.
3 months ago
Annual Secretarial Compliance Report - 31.03.2026.
3 months ago

Concalls & investor presentations

Nov 2025
ConcallPresentation
Aug 2025
ConcallPresentation
Aug 2025
Nov 2024
ConcallPresentation
Nov 2024
Aug 2023
Nov 2021
ConcallPresentation
Aug 2021
ConcallPresentation
Aug 2021
May 2021

Epigral Ltd Share Price Today

The Epigral Ltd share price today is ₹1212.70. During the trading session, the Epigral Ltd share price opened at ₹1228.00 and recorded an intraday high of ₹1231.80 and a low of ₹1207.30. Last closing price was ₹1219.70. Over the past 52 weeks, the Epigral Ltd share price has ranged between ₹807.00 and ₹1808.80. The current Epigral Ltd stock price reflects real-time market activity based on executed trades on the exchange.